WallStSmart

N-Able Inc (NABL)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

N-Able Inc generates 98% more annual revenue ($511.43M vs $258.90M). NABL leads profitability with a -3.3% profit margin vs -15.5%. ZEPP earns a higher WallStSmart Score of 38/100 (F).

NABL

Hold

37

out of 100

Grade: F

Growth: 5.3Profit: 2.5Value: 6.7Quality: 4.3
Piotroski: 2/9Altman Z: 1.37

ZEPP

Hold

38

out of 100

Grade: F

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

NABLUndervalued (+56.2%)

Margin of Safety

+56.2%

Fair Value

$12.42

Current Price

$5.31

$7.11 discount

UndervaluedFair: $12.42Overvalued
ZEPPUndervalued (+48.9%)

Margin of Safety

+48.9%

Fair Value

$46.96

Current Price

$18.01

$28.95 discount

UndervaluedFair: $46.96Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NABL1 strengths · Avg: 10.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

NABL4 concerns · Avg: 2.5/10
Market CapQuality
$1.00B3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-2.2%2/10

ROE of -2.2% — below average capital efficiency

EPS GrowthGrowth
-87.3%2/10

Earnings declined 87.3%

ZEPP4 concerns · Avg: 2.3/10
Market CapQuality
$270.28M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Free Cash FlowQuality
$-26.48M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : NABL

The strongest argument for NABL centers on Price/Book. Revenue growth of 11.8% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : NABL

The primary concerns for NABL are Market Cap, Piotroski F-Score, Return on Equity.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

NABL profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

NABL generates stronger free cash flow (21M), providing more financial flexibility.

Bottom Line

ZEPP scores higher overall (38/100 vs 37/100) and 43.0% revenue growth. NABL offers better value entry with a 56.2% margin of safety. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

N-Able Inc

TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA

N-able Inc. (NABL) stands at the forefront of the managed services sector, delivering advanced cloud-based software solutions designed specifically for managed service providers (MSPs). Its robust platform streamlines IT management and security, allowing MSPs to enhance operational efficiency and elevate service delivery. As demand for cybersecurity and remote monitoring services escalates, N-able is well-positioned to leverage these trends, demonstrating strong growth potential. The company’s dedication to innovation and expanding market reach makes it an appealing investment opportunity for institutional investors targeting the technology landscape.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?